Core Laboratories CLB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$753K-1,191% | $5.13M-31.3% | $14.52M+21.0% | $10.67M+16.1% | $69K-98.0% | ||
| $3.76M+1.3% | $3.67M+0.1% | $3.59M-2.2% | $3.67M-2.7% | $3.72M-3.3% | ||
| $5.03M+21.0% | $1.11M— | $1.33M— | $538K— | $4.16M-13.7% | ||
| $3.97M-40.5% | $7.95M-61.5% | $8.5M-35.1% | $13.92M-18.8% | $6.66M+20.4% | ||
| $3.45M+23.8% | $2.94M-9.2% | $2.01M-26.5% | $3.47M+21.2% | $2.79M-8.7% | ||
| -$3.39M-539% | -$3.75M-5.4% | $2.39M+587% | -$1.64M-139% | $772K+147% | ||
| $460K-1.9% | $466K-0.6% | $465K-0.9% | $469K-0.2% | $469K+0.2% | ||
| $4M+97.7% | $2.66M-45.8% | $5.01M+2,456% | $2.74M+1,591% | $2.02M+4,495% | ||
| $66M+408% | $12M+100% | $11M-31.3% | $12M+50.0% | $13M-7.1% | ||
| $62M+313% | $16M-20.0% | $20M-16.7% | $12M-42.9% | $15M-11.8% | ||
| -$457K+89.8% | -$7.12M+63.2% | -$16.45M-86.4% | -$3.2M+76.6% | -$4.48M-9.9% | ||
| $117K-96.0% | —— | —— | $9.08M+226% | $2.95M+1,525% | ||
| $517K-86.7% | $5M-71.2% | $6.5M-37.3% | $10.45M-26.8% | $3.88M+56.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Core Laboratories generate?
- Core Laboratories (CLB) generated $34.3M in operating cash flow over the trailing twelve months.
- What is Core Laboratories's free cash flow?
- After $11.9M of capital expenditures, Core Laboratories's free cash flow was $22.5M over the trailing twelve months, down 51.1% year over year.
- Where does Core Laboratories's cash flow data come from?
- Every line is extracted from Core Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
